Redburn Upgrades Moderna (MRNA) to Neutral
Get Alerts MRNA Hot Sheet
Price: $142.85 --0%
Rating Summary:
8 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 10 | New: 8
Rating Summary:
8 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 10 | New: 8
Join SI Premium – FREE
Redburn analyst Simon Baker upgraded Moderna (NASDAQ: MRNA) from Sell to Neutral.
For an analyst ratings summary and ratings history on Moderna click here. For more ratings news on Moderna click here.
Shares of Moderna closed at $169.33 yesterday.
You May Also Be Interested In
- UPDATE: Atlantic Equities Upgrades First Republic Bank (FRC) to Overweight
- U.S. FDA advisers recommend change to COVID vaccine composition for fall
- UPDATE: RBC Capital Upgrades Sitio Royalties (STR) to Outperform
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!